The nationally recognized Nemeroff Law Firm won a major victory for victims of occupational diseases in Pennsylvania. In a landmark decision, the Pennsylvania Supreme Court reversed a Superior Court decision and recognized an employee’s right to bring a civil action against an employer for a latent occupational disease. In Landis v. A.W. Chesterton, et al. […]
NEW ORLEANS – The Dallas-based Nemeroff Law Firm is announcing a verdict on behalf of a Louisiana man who was diagnosed with malignant mesothelioma following decades of working around asbestos-containing materials at two manufacturing plants. Orleans Parish jurors deliberated for half a day on Thursday, Sept. 8, 2011, before returning the verdict in favor of […]
More than 50 Speakers and 500 Attendees Set to Explore Current Trends Driving Asbestos Litigation at the 2013 National Overview & Outlook Rick Nemeroff, owner of The Nemeroff Law Firm and leading representative of mesothelioma victims, was selected to return as co-chair and moderator for the 2013 Asbestos Litigation Conference: A National Overview and Outlook. […]
Late last month – on Tuesday, October 21 st – Johnson & Johnson’s Janssen unit announced a recall of the popular blood-thinner medication Xarelto (rivaroxaban). According to officials from Janssen, 13,500 bottles of Xarelto are being recalled after microbial contamination was found in a sample. The U.S. Food and Drug Administration (FDA) also released an […]
In the past several months, concerns over the risks and safety of Xarelto – a popular prescription blood thinner – have been on the rise. In many cases, patients who took Xarelto have reported incidents of severe and uncontrollable bleeding, some serious enough to require hospitalization. A number of injuries and deaths have been associated […]
Earlier this month, the U.S. Judicial Panel on Multidistrict Litigation announced the consolidation of federal Xarelto lawsuits in the United States District Court for the Eastern District of Louisiana. The announcement, made on December 12, is considered a turning point in nationwide litigation involving the popular blood-thinner, which has been linked to a number of […]
